{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:46:29Z","timestamp":1792853189262,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["AGM-12006"],"award-info":[{"award-number":["AGM-12006"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["192.061"],"award-info":[{"award-number":["192.061"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016958","name":"Office of Research Infrastructure Programs, National Institutes of Health","doi-asserted-by":"publisher","award":["1S10OD012289-01A1"],"award-info":[{"award-number":["1S10OD012289-01A1"]}],"id":[{"id":"10.13039\/100016958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01AI148557-01A1"],"award-info":[{"award-number":["1R01AI148557-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["ACB-12002"],"award-info":[{"award-number":["ACB-12002"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1156262"],"award-info":[{"award-number":["OPP1156262"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1126258"],"award-info":[{"award-number":["OPP1126258"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["428410"],"award-info":[{"award-number":["428410"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["OPP1179906"],"award-info":[{"award-number":["OPP1179906"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006132","name":"Office of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006126","name":"Hospital for Sick Children","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006126","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006224","name":"Argonne National Laboratory","doi-asserted-by":"publisher","award":["DE-AC02-06CH11357"],"award-info":[{"award-number":["DE-AC02-06CH11357"]}],"id":[{"id":"10.13039\/100006224","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.immuni.2022.07.015","type":"journal-article","created":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T10:38:56Z","timestamp":1660646336000},"page":"1680-1692.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Vaccination with a structure-based stabilized version of malarial antigen Pfs48\/45 elicits ultra-potent transmission-blocking antibody responses"],"prefix":"10.1016","volume":"55","author":[{"given":"Brandon","family":"McLeod","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moustafa T.","family":"Mabrouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoyo","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Ravichandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Kephart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Hailemariam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thao P.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Semesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iga","family":"Kucharska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasun","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Blackstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deleah","family":"Pettie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Leaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marga","family":"van de Vegte-Bolmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert-Jan","family":"van Gemert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordache","family":"Ramjith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Richter","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall S.","family":"MacGill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthijs M.","family":"Jore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil P.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan F.","family":"Lovell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Julien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2022.07.015_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00775-18","article-title":"Transmission-blocking vaccines: old friends and new prospects","volume":"87","author":"Acquah","year":"2019","journal-title":"Infect. Immun."},{"key":"10.1016\/j.immuni.2022.07.015_bib2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12936-017-1955-0","article-title":"Antibody responses to two new Lactococcus lactis-produced recombinant Pfs48\/45 and Pfs230 proteins increase with age in malaria patients living in the Central Region of Ghana","volume":"16","author":"Acquah","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.immuni.2022.07.015_bib3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"Phenix: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.immuni.2022.07.015_bib4","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1074-7613(94)80017-0","article-title":"Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides","volume":"1","author":"Alexander","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2022.07.015_bib5","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.3389\/fimmu.2018.02780","article-title":"Combination of RTS,S and Pfs25-IMX313 induces a functional antibody response against malaria infection and transmission in mice","volume":"9","author":"Brod","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2022.07.015_bib6","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1038\/s41467-019-12080-1","article-title":"Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle","volume":"10","author":"Brouwer","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2022.07.015_bib7","unstructured":"Chemical Computing Group (2022). Molecular Operating Environment (MOE). Chemical Computing Group ULC, 1010 Sherbooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7, 2022."},{"key":"10.1016\/j.immuni.2022.07.015_bib8","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1016\/j.vaccine.2018.08.033","article-title":"Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: a phase 1 dose-escalation study in healthy adults","volume":"36","author":"Chichester","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.immuni.2022.07.015_bib9","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1038\/s41467-021-21955-1","article-title":"A human monoclonal antibody blocks malaria transmission and defines a highly conserved neutralizing epitope on gametes","volume":"12","author":"Coelho","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2022.07.015_bib10","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2022.07.015_bib11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature12966","article-title":"Proof of principle for epitope-focused vaccine design","volume":"507","author":"Correia","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2022.07.015_bib12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1146\/annurev.biochem.77.062906.171838","article-title":"Macromolecular modeling with Rosetta","volume":"77","author":"Das","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.immuni.2022.07.015_bib13","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.pt.2018.07.001","article-title":"Antimalarial transmission-blocking interventions: past, present, and future","volume":"34","author":"Delves","year":"2018","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.immuni.2022.07.015_bib14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41541-020-0196-3","article-title":"Malaria vaccines since 2000: progress, priorities, products","volume":"5","author":"Duffy","year":"2020","journal-title":"npj Vaccines"},{"key":"10.1016\/j.immuni.2022.07.015_bib15","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.immuni.2022.07.015_bib16","series-title":"Potent Human Monoclonal Antibodies Target Different Domains of Malaria Transmission Blocking Vaccine Candidate Pfs48\/45","author":"Fabra-Garc\u00eda","year":"2021"},{"key":"10.1016\/j.immuni.2022.07.015_bib17","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nature01107","article-title":"A proteomic view of the Plasmodium falciparum life cycle","volume":"419","author":"Florens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2022.07.015_bib18","series-title":"The Proteomics Protocols Handbook","first-page":"571","article-title":"Protein identification and analysis tools on the Expasy server","author":"Gasteiger","year":"2005"},{"key":"10.1016\/j.immuni.2022.07.015_bib19","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1007\/s13361-013-0727-5","article-title":"Analysis of overlapped and noisy hydrogen\/deuterium exchange mass spectra","volume":"24","author":"Guttman","year":"2013","journal-title":"J.\u00a0Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.immuni.2022.07.015_bib20","doi-asserted-by":"crossref","first-page":"e146221","DOI":"10.1172\/JCI146221","article-title":"Pfs230 yields higher malaria transmission-blocking vaccine activity than Pfs25 in humans but not mice","volume":"131","author":"Healy","year":"2021","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2022.07.015_bib21","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.abd0826","article-title":"Structure-based design of prefusion-stabilized SARS-CoV-2 spikes","volume":"369","author":"Hsieh","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.immuni.2022.07.015_bib22","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/s41565-018-0271-3","article-title":"A malaria vaccine adjuvant based on recombinant antigen binding to liposomes","volume":"13","author":"Huang","year":"2018","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.immuni.2022.07.015_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41541-020-0173-x","article-title":"Antibody response of a particle-inducing, liposome vaccine adjuvant admixed with a Pfs230 fragment","volume":"5","author":"Huang","year":"2020","journal-title":"npj Vaccines"},{"key":"10.1016\/j.immuni.2022.07.015_bib24","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1126\/science.1234150","article-title":"Rational HIV immunogen design to target specific germline B cell receptors","volume":"340","author":"Jardine","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.immuni.2022.07.015_bib25","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41577-019-0209-5","article-title":"Antibodies against Plasmodium falciparum malaria at the molecular level","volume":"19","author":"Julien","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2022.07.015_bib26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"XDS","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.immuni.2022.07.015_bib27","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1038\/s41467-018-06742-9","article-title":"Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48\/45","volume":"9","author":"Kundu","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2022.07.015_bib28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41598-019-57384-w","article-title":"A C-terminal Pfs48\/45 malaria transmission-blocking vaccine candidate produced in the baculovirus expression system","volume":"10","author":"Lee","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.immuni.2022.07.015_bib29","doi-asserted-by":"crossref","first-page":"119843","DOI":"10.1016\/j.ijpharm.2020.119843","article-title":"Lyophilized, antigen-bound liposomes with reduced MPLA and enhanced thermostability","volume":"589","author":"Mabrouk","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.immuni.2022.07.015_bib30","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1126\/sciadv.abj1476","article-title":"Lyophilized, thermostable Spike or RBD immunogenic liposomes induce protective immunity against SARS-CoV-2 in mice","volume":"7","author":"Mabrouk","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.immuni.2022.07.015_bib31","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jsb.2013.11.002","article-title":"Fabrication of carbon films with \u223c 500nm holes for cryo-EM with a direct detector device","volume":"185","author":"Marr","year":"2014","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.immuni.2022.07.015_bib32","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.immuni.2022.07.015_bib33","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.immuni.2022.07.015_bib34","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1038\/s41467-019-11980-6","article-title":"Potent antibody lineage against malaria transmission elicited by human vaccination with Pfs25","volume":"10","author":"McLeod","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2022.07.015_bib35","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.vaccine.2019.02.071","article-title":"ELISA units, IgG subclass ratio and avidity determined functional activity of mouse anti-Pfs230 antibodies judged by a standard membrane-feeding assay with Plasmodium falciparum","volume":"37","author":"Miura","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.immuni.2022.07.015_bib36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.vaccine.2007.10.064","article-title":"Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines","volume":"26","author":"Miura","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.immuni.2022.07.015_bib37","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1016\/j.vaccine.2016.06.066","article-title":"Transmission-blocking activity is determined by transmission-reducing activity and number of control oocysts in Plasmodium falciparum standard membrane-feeding assay","volume":"34","author":"Miura","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.immuni.2022.07.015_bib38","doi-asserted-by":"crossref","first-page":"e57909","DOI":"10.1371\/journal.pone.0057909","article-title":"Qualification of standard membrane-feeding assay with plasmodium falciparum malaria and potential improvements for future assays","volume":"8","author":"Miura","year":"2013","journal-title":"PLoS one"},{"key":"10.1016\/j.immuni.2022.07.015_bib39","doi-asserted-by":"crossref","first-page":"e01456","DOI":"10.7554\/eLife.01456","article-title":"Collaboration gets the most out of software","volume":"2","author":"Morin","year":"2013","journal-title":"eLife"},{"key":"10.1016\/j.immuni.2022.07.015_bib40","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1073\/pnas.0800459105","article-title":"Correctly folded Pfs48\/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice","volume":"105","author":"Outchkourov","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2022.07.015_bib41","series-title":"Technical Note: malaria vaccine and priorities for malaria elimination in the Americas","year":"2021"},{"key":"10.1016\/j.immuni.2022.07.015_bib42","doi-asserted-by":"crossref","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","article-title":"Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen","volume":"114","author":"Pallesen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2022.07.015_bib43","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1017\/S0031182000062065","article-title":"Infectivity of cultured Plasmodium falciparum gametocytes to mosquitoes","volume":"98","author":"Ponnudurai","year":"1989","journal-title":"Parasitology"},{"key":"10.1016\/j.immuni.2022.07.015_bib44","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41541-021-00407-3","article-title":"Malaria transmission-blocking conjugate vaccine in ALFQ adjuvant induces durable functional immune responses in rhesus macaques","volume":"6","author":"Scaria","year":"2021","journal-title":"npj Vaccines"},{"key":"10.1016\/j.immuni.2022.07.015_bib45","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1016\/j.vaccine.2020.06.018","article-title":"Comparison of carrier proteins to conjugate malaria transmission blocking vaccine antigens, Pfs25 and Pfs230","volume":"38","author":"Scaria","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.immuni.2022.07.015_bib46","doi-asserted-by":"crossref","first-page":"e35213","DOI":"10.7554\/eLife.35213","article-title":"Synergy in anti-malarial pre-erythrocytic and transmission-blocking antibodies is achieved by reducing parasite density","volume":"7","author":"Sherrard-Smith","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.immuni.2022.07.015_bib47","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.vaccine.2015.02.040","article-title":"A Plasmodium falciparum 48\/45 single epitope R0.6C subunit protein elicits high levels of transmission blocking antibodies","volume":"33","author":"Singh","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.immuni.2022.07.015_bib48","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1016\/j.vaccine.2017.05.054","article-title":"Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48\/45 based vaccine antigen by SpyTag\/SpyCatcher mediated virus-like display","volume":"35","author":"Singh","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.immuni.2022.07.015_bib49","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.3389\/fimmu.2019.01256","article-title":"Pfs230 and Pfs48\/45 fusion proteins elicit strong transmission-blocking antibody responses against plasmodium falciparum","volume":"10","author":"Singh","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2022.07.015_bib50","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.3389\/fimmu.2020.606266","article-title":"A reproducible and scalable process for manufacturing a Pfs48\/45 based Plasmodium falciparum transmission-blocking vaccine","volume":"11","author":"Singh","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2022.07.015_bib51","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41467-017-02646-2","article-title":"Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity","volume":"9","author":"Stone","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2022.07.015_bib52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1017\/S0031182015001341","article-title":"Naturally acquired immunity to sexual stage P.\u00a0falciparum parasites","volume":"143","author":"Stone","year":"2016","journal-title":"Parasitology"},{"key":"10.1016\/j.immuni.2022.07.015_bib53","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/microorganisms7060179","article-title":"Malaria: the past and the present","volume":"7","author":"Talapko","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.immuni.2022.07.015_bib54","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1056\/NEJMoa1208394","article-title":"A Phase 3 trial of RTS,S\/AS01 malaria vaccine in African infants","volume":"367","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2022.07.015_bib55","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1017\/S1431927608080781","article-title":"An improved cryogen for plunge freezing","volume":"14","author":"Tivol","year":"2008","journal-title":"Microsc. Microanal."},{"key":"10.1016\/j.immuni.2022.07.015_bib56","series-title":"First-in-Human Evaluation of a Plasmodium falciparum Transmission-Blocking Monoclonal Antibody","author":"van der Boor","year":"2020"},{"key":"10.1016\/j.immuni.2022.07.015_bib57","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0092-8674(01)00199-4","article-title":"A central role for P48\/45 in malaria parasite male gamete fertility","volume":"104","author":"van Dijk","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2022.07.015_bib58","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1128\/JVI.01351-16","article-title":"Epitope-independent purification of native-like envelope trimers from diverse HIV-1 isolates","volume":"90","author":"Verkerke","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2022.07.015_bib59","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.jasms.2006.07.025","article-title":"Semi-automated data processing of hydrogen exchange mass spectra using HX-Express","volume":"17","author":"Weis","year":"2006","journal-title":"J.\u00a0Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.immuni.2022.07.015_bib60","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S1473-3099(15)00239-X","article-title":"Immunogenicity of the RTS,S\/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial","volume":"15","author":"White","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.immuni.2022.07.015_bib61","series-title":"World malaria report 2021","year":"2021"},{"key":"10.1016\/j.immuni.2022.07.015_bib62","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41541-021-00392-7","article-title":"A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge","volume":"6","author":"Wuertz","year":"2021","journal-title":"npj Vaccines"}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761322003508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761322003508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:10:55Z","timestamp":1778587855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761322003508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":62,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1074761322003508"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2022.07.015","relation":{},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination with a structure-based stabilized version of malarial antigen Pfs48\/45 elicits ultra-potent transmission-blocking antibody responses","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2022.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}